Private company
MRL Ventures Fund LLC
American company, incorporated in Delaware. Summary from the record
Last updated Oct 21, 2026.
Overview
- HeadquartersDE1
Corporate structure
MRL Ventures Fund LLC is part of a group headed by Merck & Co.. 349 entities, 69 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
- Merck & Co. Rahway, New Jersey, United States
- MRL Ventures Fund LLC DE
- Entrada Therapeutics, Inc. Stake · Boston, Massachusetts
- Xilio Therapeutics, Inc. Stake · Waltham, Massachusetts
- MSD Sharp & Dohme GmbH München, Germany
- Merck (Japan) Subsidiary · Tokyo, Japan
- Merck Sharp & Dohme Latvija, SIA Subsidiary · Riga, Latvia
- Merck Sharp & Dohme, UAB Subsidiary · Vilnius, Lithuania
- MSD (Netherlands) Subsidiary · Amsterdam, Netherlands
- MSD Norway AS Subsidiary · Drammen, Norway
- Sirna Therapeutics Subsidiary · San Francisco
- 7728026 Canada Inc. Subsidiary · Canada
- Abceutics, Inc. Subsidiary · Delaware, United States
- Abmaxis Inc. Subsidiary · Delaware, United States
- Acceleron Pharma Inc. Subsidiary · Delaware, United States
- Afferent Pharmaceuticals, Inc. Subsidiary · Delaware, United States
- Agrident GmbH Subsidiary · Germany
- Allflex (China) Intelligent Technology Co. Ltd. Subsidiary · China
- Allflex Argentina S.A. Subsidiary · Argentina
- Allflex Australia Pty. Ltd. Subsidiary · Australia
- Allflex Dan-Mark ApS Subsidiary · Denmark
- Allflex Europe S.A.S. Subsidiary · France
- Allflex Group Germany GmbH Subsidiary · Germany
- ALLFLEX INDIA PRIVATE LIMITED Subsidiary · Gurugram, India
- Allflex Maroc S.A.R.L. Subsidiary · Morocco
- Allflex New Zealand Subsidiary · New Zealand
- Allflex Polska Spolka z ograniczona odpowiedzialnoscia Subsidiary · Poland
- Allflex Romania S.R.L. Subsidiary · Romania
- and 316 more
- MRL Ventures Fund LLC DE
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; subsidiaries, stakes and holdings from Wikidata (CC0); stakes of 5% or more it reported on Schedules 13D and 13G (2 companies). Each entity in the chart links to its source.
Stakes it holds
MRL Ventures Fund LLC has told the SEC it owns more than 5% of 2 companies, latest first (Schedules 13D and 13G).
- Xilio Therapeutics, Inc.SC 13G Apr 10, 20232
- Entrada Therapeutics, Inc.SC 13G Feb 8, 20223
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3